ATE490954T1 - Estergebundene geminitensidverbindungen zur verwendung in der gentherapie - Google Patents
Estergebundene geminitensidverbindungen zur verwendung in der gentherapieInfo
- Publication number
- ATE490954T1 ATE490954T1 AT06701592T AT06701592T ATE490954T1 AT E490954 T1 ATE490954 T1 AT E490954T1 AT 06701592 T AT06701592 T AT 06701592T AT 06701592 T AT06701592 T AT 06701592T AT E490954 T1 ATE490954 T1 AT E490954T1
- Authority
- AT
- Austria
- Prior art keywords
- ester
- gemini surfactant
- surfactant compounds
- gene therapy
- linked
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000004094 surface-active agent Substances 0.000 title abstract 3
- 238000001415 gene therapy Methods 0.000 title 1
- 150000002148 esters Chemical class 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0502482.3A GB0502482D0 (en) | 2005-02-07 | 2005-02-07 | Novel compounds |
| PCT/EP2006/000998 WO2006082088A1 (en) | 2005-02-07 | 2006-02-03 | Ester-linked gemini surfactant compounds for use in gene therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE490954T1 true ATE490954T1 (de) | 2010-12-15 |
Family
ID=34355904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06701592T ATE490954T1 (de) | 2005-02-07 | 2006-02-03 | Estergebundene geminitensidverbindungen zur verwendung in der gentherapie |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7425645B2 (de) |
| EP (1) | EP1848684B1 (de) |
| JP (1) | JP4991567B2 (de) |
| AT (1) | ATE490954T1 (de) |
| DE (1) | DE602006018709D1 (de) |
| ES (1) | ES2357140T3 (de) |
| GB (1) | GB0502482D0 (de) |
| WO (1) | WO2006082088A1 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006138380A2 (en) | 2005-06-15 | 2006-12-28 | Massachusetts Institute Of Technology | Amine-containing lipids and uses thereof |
| CA3144493A1 (en) * | 2006-10-03 | 2008-04-10 | Arbutus Biopharma Corporation | Lipid containing formulations |
| WO2010053572A2 (en) | 2008-11-07 | 2010-05-14 | Massachusetts Institute Of Technology | Aminoalcohol lipidoids and uses thereof |
| SI2506857T1 (en) | 2009-12-01 | 2018-08-31 | Translate Bio, Inc. | Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases |
| US9193827B2 (en) | 2010-08-26 | 2015-11-24 | Massachusetts Institute Of Technology | Poly(beta-amino alcohols), their preparation, and uses thereof |
| ES2702428T3 (es) * | 2010-11-15 | 2019-02-28 | Life Technologies Corp | Reactivos de transfección que contienen amina y métodos para prepararlos y usarlos |
| US8546338B2 (en) | 2010-12-08 | 2013-10-01 | Johnson & Johnson Consumer Companies, Inc. | Self-assembling hydrogels based on dicephalic peptide amphiphiles |
| CA2831392C (en) | 2011-03-28 | 2020-04-28 | Massachusetts Institute Of Technology | Conjugated lipomers and uses thereof |
| KR20220025112A (ko) | 2011-06-08 | 2022-03-03 | 샤이어 휴먼 지네틱 테라피즈 인크. | Mrna 전달을 위한 지질 나노입자 조성물 및 방법 |
| US9512073B2 (en) | 2011-10-27 | 2016-12-06 | Massachusetts Institute Of Technology | Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof |
| EP3536787A1 (de) | 2012-06-08 | 2019-09-11 | Translate Bio, Inc. | Nukleaseresistente polynukleotide und verwendungen davon |
| WO2014028487A1 (en) | 2012-08-13 | 2014-02-20 | Massachusetts Institute Of Technology | Amine-containing lipidoids and uses thereof |
| KR102311614B1 (ko) | 2013-03-14 | 2021-10-08 | 샤이어 휴먼 지네틱 테라피즈 인크. | Cftr mrna 조성물 및 관련 방법 및 사용 |
| EA201591229A1 (ru) | 2013-03-14 | 2016-01-29 | Шир Хьюман Дженетик Терапис, Инк. | Способы очистки матричной рнк |
| US9315472B2 (en) | 2013-05-01 | 2016-04-19 | Massachusetts Institute Of Technology | 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof |
| ES2707966T3 (es) | 2013-10-22 | 2019-04-08 | Translate Bio Inc | Terapia de ARNm para la deficiencia en síntesis de argininosuccinato |
| EP3574923A1 (de) | 2013-10-22 | 2019-12-04 | Translate Bio, Inc. | Mrna-therapie für phenylketonurie |
| ES3032935T3 (en) | 2013-10-22 | 2025-07-29 | Translate Bio Inc | Lipid formulations for delivery of messenger rna |
| EP4729528A3 (de) | 2014-04-25 | 2026-06-24 | Translate Bio, Inc. | Verfahren zur reinigung von messenger-rna |
| WO2015184256A2 (en) | 2014-05-30 | 2015-12-03 | Shire Human Genetic Therapies, Inc. | Biodegradable lipids for delivery of nucleic acids |
| KR102559979B1 (ko) | 2014-06-24 | 2023-07-25 | 샤이어 휴먼 지네틱 테라피즈 인크. | 핵산의 전달용 입체화학적으로 풍부한 조성물 |
| WO2016004202A1 (en) | 2014-07-02 | 2016-01-07 | Massachusetts Institute Of Technology | Polyamine-fatty acid derived lipidoids and uses thereof |
| RS64331B1 (sr) | 2015-06-19 | 2023-08-31 | Massachusetts Inst Technology | Alkenil supstituisani 2,5-piperazindioni i njihova primena u sastavima za isporuku agensa u organizam ili ćeliju subjekta |
| MX2019010155A (es) | 2017-02-27 | 2020-12-10 | Translate Bio Inc | Arnm de cftr optimizado por codón novedoso. |
| IL270631B2 (en) | 2017-05-16 | 2024-03-01 | Translate Bio Inc | Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding cftr |
| US11174500B2 (en) | 2018-08-24 | 2021-11-16 | Translate Bio, Inc. | Methods for purification of messenger RNA |
| AU2019384557B2 (en) | 2018-11-21 | 2025-07-17 | Translate Bio, Inc. | Treatment of cystic fibrosis by delivery of nebulized mRNA encoding CFTR |
| CA3155003A1 (en) | 2019-09-20 | 2021-03-25 | Translate Bio, Inc. | Mrna encoding engineered cftr |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5565290A (en) * | 1991-07-30 | 1996-10-15 | Fuji Photo Film Co., Ltd. | Desensitizing solution for offset printing |
| JPH05104878A (ja) * | 1991-10-17 | 1993-04-27 | Fuji Photo Film Co Ltd | オフセツト印刷用不感脂化処理液 |
| DE69420044T2 (de) | 1993-10-29 | 2000-03-23 | Smithkline Beecham Corp., King Of Prussia | Blutregulierende peptide |
| JP3878208B2 (ja) * | 1994-04-08 | 2007-02-07 | ブラッコ インターナショナル ベスローテン フェンノートシャップ | 芳香族アミド化合物およびそれらのキレート |
| WO1998008496A1 (en) * | 1996-08-27 | 1998-03-05 | The University Of Akron | Lipophilic polyamine esters for the site specific delivery of nitric oxide in pharmaceutical use |
| GB9914045D0 (en) * | 1999-06-16 | 1999-08-18 | Smithkline Beecham Plc | Novel compounds |
| EP1261620A2 (de) * | 2000-02-07 | 2002-12-04 | Roche Diagnostics Corporation | Kationische amphiphile zur verwendung bei der nucleinsäuretransfektin |
| WO2004087656A1 (de) | 2003-04-03 | 2004-10-14 | Schering Aktiengesellschaft | Konjugate 2,4-ethano- und 2,4-propano-überbrückter 3,6,9-triaza-nonansäure-3n, 6n, 9,9n-tetraessigsäure- und entsprechender phosphorsäuremethylen-derivate und deren abkömmlinge mit biomolekülen, verfahren zu deren herstellung und deren verwendung zur herstellung |
| GB0425556D0 (en) * | 2004-11-19 | 2004-12-22 | Glaxo Group Ltd | Novel compounds |
| GB0425555D0 (en) * | 2004-11-19 | 2004-12-22 | Glaxo Group Ltd | Novel compounds |
-
2005
- 2005-02-07 GB GBGB0502482.3A patent/GB0502482D0/en not_active Ceased
-
2006
- 2006-02-03 DE DE602006018709T patent/DE602006018709D1/de not_active Expired - Lifetime
- 2006-02-03 ES ES06701592T patent/ES2357140T3/es not_active Expired - Lifetime
- 2006-02-03 AT AT06701592T patent/ATE490954T1/de not_active IP Right Cessation
- 2006-02-03 WO PCT/EP2006/000998 patent/WO2006082088A1/en not_active Ceased
- 2006-02-03 US US11/815,570 patent/US7425645B2/en not_active Expired - Fee Related
- 2006-02-03 JP JP2007553550A patent/JP4991567B2/ja not_active Expired - Fee Related
- 2006-02-03 EP EP06701592A patent/EP1848684B1/de not_active Expired - Lifetime
-
2008
- 2008-08-04 US US12/185,144 patent/US7569720B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20080058279A1 (en) | 2008-03-06 |
| EP1848684A1 (de) | 2007-10-31 |
| US7569720B2 (en) | 2009-08-04 |
| WO2006082088A1 (en) | 2006-08-10 |
| DE602006018709D1 (de) | 2011-01-20 |
| GB0502482D0 (en) | 2005-03-16 |
| JP4991567B2 (ja) | 2012-08-01 |
| JP2009525259A (ja) | 2009-07-09 |
| US20080293829A1 (en) | 2008-11-27 |
| EP1848684B1 (de) | 2010-12-08 |
| ES2357140T3 (es) | 2011-04-19 |
| US7425645B2 (en) | 2008-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006018709D1 (de) | Estergebundene geminitensidverbindungen zur verwendung in der gentherapie | |
| CY1122522T1 (el) | Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος | |
| TW200604184A (en) | Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors | |
| TN2012000142A1 (en) | Pyrimidine derivatives as protein tyrosine kinase 2 inhibitors | |
| MX392756B (es) | Pirimidinas modificadas en la posicion 5 y su uso | |
| UA101478C2 (ru) | Соединения, полезные как ингибиторы raf-киназы | |
| JO3134B1 (ar) | مثبطات نشاط akt | |
| ZA200701137B (en) | Triazolophthalazines | |
| MY159230A (en) | P38 map kinase inhibitors | |
| NZ607996A (en) | Substituted nucleotide analogs | |
| DE602005013775D1 (de) | Verbesserte methode zur transformation von sojabohnen | |
| SI1827441T1 (sl) | Kombinacije za zdravljenje bolezni, povezanih s celično proliferacijo | |
| TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
| CY1110860T1 (el) | Αναστροφη μεταγραφαση τελομερασης πτηνου | |
| MX2009014247A (es) | Compuestos heterociclicos utiles como inhibidores de mk2. | |
| WO2006072615A3 (en) | Triazolophthalazines as pde2-inhibitors | |
| MX2010001490A (es) | Acidos nucleicos de enlace sdf-1 y uso de los mismos. | |
| DK2089516T3 (da) | Fremgangsmåder til at forbedre indføringen af DNA i bakterielle celler | |
| MX2011001679A (es) | Derivados de flavina. | |
| WO2008043543A3 (de) | Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology | |
| WO2006072612A3 (en) | Triazolophthalazines as pde2- inhibitors | |
| EP2116598A4 (de) | Neuartige beta-galactosid-alpha-2,6-sialyltransferase, gen zu deren kodierung und verfahren zur erhöhung der enzymatischen aktivität | |
| DE602007011324D1 (de) | Verfahren zur herstellung von 2-substituierten 5-(1-alkylthio)alkylpyridinen | |
| PL1924717T3 (pl) | Sposoby zwiększania odwadnialności osadu ściekowego przez obróbkę alfa-amylazą | |
| MX2009009916A (es) | Tetrahidroquinolinas sustituidas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |